Latest News

Be Wary of TikTok Content on Infantile Hemangiomas: Study


 

TOPLINE:

The accuracy of information on TikTok videos about infantile hemangiomas (IHs) varies widely, researchers found.

METHODOLOGY:

  • New parents may turn to TikTok for information about IHs, but little is known about the quality of videos on the social media platform related to the topic.
  • Using the search term “hemangioma,” researchers reviewed the top 50 English-language TikTok videos that resulted from the query in November 2022.
  • The researchers analyzed the videos for their content source, accuracy, and purpose and used Infantile Hemangioma Referral Score criteria to determine if the lesions pictured on the videos met criteria for referral to a specialist or not.

TAKEAWAY:

  • Combined, the 50 videos were viewed 25.1 million times, had 2.6 million likes, and received 17,600 comments.
  • Only 36 were considered likely to be IH. Of those 36 videos, the researchers deemed 33 (92%) to be potentially problematic, meriting referral to a specialist. The remaining three lesions could not be classified because of insufficient information.
  • Of the 50 videos, 45 were created by individuals personally affected by IH (parents of a child with IH or young adults living with residual impacts), and only three were created by physicians (two by plastic surgeons and one by a neonatologist).
  • In terms of content, 2 of the 45 videos created by someone personally affected by IH contained inaccurate information, while all three of videos created by physicians contained inaccurate information, such as oversimplification of the prognosis or incorrect nomenclature.

IN PRACTICE:

“Providers should be aware that TikTok may be useful for promoting birthmark awareness, but that it should not be relied on for accurate information about IHs,” the authors wrote.

SOURCE:

First author Sonora Yun, a medical student at Columbia University College of Physicians and Surgeons, New York City, conducted the research with Maria C. Garzon, MD, and Kimberly D. Morel, MD, who are board-certified pediatric dermatologists at Columbia. The study was published in Pediatric Dermatology.

LIMITATIONS:

The authors noted no specific limitations to the study.

DISCLOSURES:

The researchers reported having no disclosures.

A version of this article appeared on Medscape.com.

Recommended Reading

Management of Tinea Capitis in Children Varies, Survey Finds
MDedge Dermatology
Tapinarof Cream Under FDA Review for Atopic Dermatitis Indication
MDedge Dermatology
An 8-Year-Old Male With Asymptomatic Brown Rough Plaques on the Dorsum of the Right Hand and Fingers, Accompanied by Widening of the Knuckles
MDedge Dermatology
Company Announces Regulatory Filing for Nemolizumab for Two Indications
MDedge Dermatology
What Skin Manifestations Are Associated With Pediatric IBD?
MDedge Dermatology
Unleashing Our Immune Response to Quash Cancer
MDedge Dermatology
Democratic Lawmakers Press Pfizer on Chemotherapy Drug Shortages
MDedge Dermatology
FDA Approves 10th Humira Biosimilar, With Interchangeability
MDedge Dermatology
Climate Change and AD: New Review Shows Negative Impacts and Unknowns
MDedge Dermatology
Omalizumab for Food Allergies: What PCPs Should Know
MDedge Dermatology